Aomics (Drug Discovery) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Aomics (Drug Discovery) General Information

Description

Developer of an anti-cancer drug based in Carlsbad, United States. The company develops drugs by fusing an antibody to the paclitaxel molecule, enabling patients to cure themselves and be healthy and safe.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 6076 Corte Del Cedro
  • Carlsbad, CA 92011
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 6076 Corte Del Cedro
  • Carlsbad, CA 92011
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aomics (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-Oct-2015 Completed Startup
To view Aomics (Drug Discovery)’s complete valuation and funding history, request access »

Aomics (Drug Discovery) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bio, Tech and Beyond Accelerator/Incubator
To view Aomics (Drug Discovery)’s complete investors history, request access »

Ready to get started?

Request a free trial

Aomics (Drug Discovery) FAQs

  • When was Aomics (Drug Discovery) founded?

    Aomics (Drug Discovery) was founded in 2015.

  • Where is Aomics (Drug Discovery) headquartered?

    Aomics (Drug Discovery) is headquartered in Carlsbad, CA.

  • What industry is Aomics (Drug Discovery) in?

    Aomics (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Aomics (Drug Discovery) a private or public company?

    Aomics (Drug Discovery) is a Private company.

  • What is Aomics (Drug Discovery)’s current revenue?

    The current revenue for Aomics (Drug Discovery) is .

  • Who are Aomics (Drug Discovery)’s investors?

    Bio, Tech and Beyond has invested in Aomics (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »